kentucky glp-1 gi obstruction lawsuit Dallas-Fort Worth Ozempic Lawyer Health Canada Warns of Unauthorised
Description
The study was published in March 2024, and found that about 10% of adults in Canada had used a GLP-1 type drug between 900,000 and 1.4 million consumers
Retatrutide hit 28.3% weight loss in the May 2026 trial
The study was published in JACC: Clinical Electrophysiology and presented at the American College of Cardiology Scientific Session.
To further note, in the field of weight-loss treatment, significant work is underway in parallel, on GIP agonist, amylin agonist, glucagon agonist, PYY agonist, either separately or in combination especially with GLP-1 agonist.
GLP-1 injectable medications can cost $900$1,500 monthly through traditional pharmacy channels
